Cytel unlocks innovative clinical development expertise for APAC biopharma sector
Cytel has now established entities in Australia, Shanghai, Beijing, and Singapore, and plans to expand into Seoul and Tokyo in the coming years.
Cytel has now established entities in Australia, Shanghai, Beijing, and Singapore, and plans to expand into Seoul and Tokyo in the coming years.
The decision is based on the outcome of a prespecified interim analysis of the Phase 3 AMEERA-5 trial
Ministry of Ayush signed a MoU with Ministry of Micro, Small & Medium Enterprises (MSME) for the promotion of Ayush enterprises.
Ministry of Ayush has fast tracked up-gradation and construction of various Ayush Infrastructure across the country
Orion to receive an upfront payment of USD 290 million
Advancing to IND-enabling studies with multiple drug candidates
Granite Bio's lead candidate is a novel monoclonal antibody for treatment of autoimmune and certain cancer indications. B
The ground floor of the formulation development laboratory is focused on solid orals, the first floor on injections, and the second floor houses the analytical lab
Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets
 
        Subscribe To Our Newsletter & Stay Updated